GEN News Highlights

Aug 18 2008, 11:28 AM EST

Beckman Coulter Obtains Full Rights to Nephromics’ Preeclampsia Test

GEN News Highlights

Beckman Coulter has bought its royalty obligations to Nephromics, which covers a preeclampsia test in development. In addition, Beckman Coulter obtained rights to acquire the worldwide diagnostics assets of Nephromics.

Beckman Coulter has began evaluating the preeclampsia product in a clinical trial. The new tests are being designed for detection, monitoring, and risk assessment. The company plans to begin offering the tests by the end of 2009.

The device is undergoing development on the company's family of UniCel® DxI and Access® immunoassay systems as well as UniCel DxCi chemistry-immunoassay work cells.

Comment on this News:

CAREER CENTER

visit the Career Center

WEBINARS

GEN Webinars: Novel Approaches for Lipid Profiling and Analysis
Date: Wednesday, February 17, 2010
This webinar will highlight the importance of chromatography in lipidomic studies, the advantages of ...learn more.

view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: RNAi!

PODCASTS

INTERVIEW: NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates ...MORE

MOST POPULAR

News

Most Viewed	Most Emailed	Top Searches
Gene Variant that Optimizes Thinking but Increases Risk of Schizophrenia Identified by NIM...
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discove...
Life Technologies Gains on Race toward $1,000 Genome
U87MG Glioblastoma Cell Line Sequenced in Under a Month
Case against the Patentability of Genes Begins Today
Merck & Co. Taps Envoy for Target Discovery in Diabetes and Obesity

Most Viewed	Most Emailed	Top Searches
Assay that Examines Hundreds of Proteins Simultaneously Invented
Scientists Solve 3-D Crystal Structure of Retroviral Integrase Bound to Viral DNA
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discove...
Life Technologies Gains on Race toward $1,000 Genome
Case against the Patentability of Genes Begins Today
U87MG Glioblastoma Cell Line Sequenced in Under a Month

Most Viewed	Most Emailed	Top Searches
Scientists Solve 3-D Crystal Structure of Retroviral Integrase Bound to Viral DNA
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discove...
U87MG Glioblastoma Cell Line Sequenced in Under a Month
EC Sanctions Roche’s Herceptin for HER2-Positive Metastatic Gastric Cancer
Scientists Identify Pathway that Helps Pancreatic Cancer Surpass Chemotherapy
Investigators Identify Gene with Prognostic Value for Breast Cancer

Articles

Most Viewed	Most Emailed	Top Searches
Dissecting Cancer Stem Cell Theories
Insights Accrue on Epigenetic Modification
Epigenetic Research Surges on Many Fronts
Court Ruling Could Lengthen Patent Term
Epigenetics Offers Strategies for New Drugs
Healing the Achilles Heel of Proteomics

Most Viewed	Most Emailed	Top Searches
Epigenetic Research Surges on Many Fronts
Court Ruling Could Lengthen Patent Term
Microbioreactors Carve Out Growing Niche
Finding the Right Outsourcing Balance
Insights Accrue on Epigenetic Modification
Epigenetics Offers Strategies for New Drugs

Most Viewed	Most Emailed	Top Searches
EcoBiotics Scours Rainforest for Compounds
Optimizing CHO Cell Culture Conditions
Funding Embryonic Stem Cell Research
Epigenetic Research Surges on Many Fronts
Dissecting Cancer Stem Cell Theories
Epigenetics Offers Strategies for New Drugs

Blogs

Most Viewed	Most Emailed	Top Searches
LabAuto 2010
Academics who Work in Industry - At What Cost?
It’s the process, stupid. Biofuels from microalgae are not yet sustainable.
Mammography Guidelines - Bring on the Controversy!
Genetically Modified Foods Debate
New Prognostic Genetic Test for Adolescent Scoliosis

Most Viewed	Most Emailed	Top Searches
Biosimilar Approval in the U.S. and Europe: How Similar Are They?
It’s the process, stupid. Biofuels from microalgae are not yet sustainable.
Academics who Work in Industry - At What Cost?

Most Viewed	Most Emailed	Top Searches
Genetically Modified Foods Debate
LabAuto 2010
It’s the process, stupid. Biofuels from microalgae are not yet sustainable.
Biosimilar Approval in the U.S. and Europe: How Similar Are They?
Drug Target Identification and Validation
Dr. James Watson Controversy

Name:
Title:
Comment:
	HELP US FIGHT SPAMMING ROBOTS by answering the following simple question. It will verify you as a legitimate user wishing to post a comment. Thank you for your cooperation.

CURRENT ISSUE

SUBSCRIBE

AD LINK

GEN News Highlights